 
                        | Product NDC: | 54575-098 | 
| Proprietary Name: | QUACK GRASS POLLEN | 
| Non Proprietary Name: | elymus repens pollen | 
| Active Ingredient(s): | 1 g/20mL & nbsp; elymus repens pollen | 
| Administration Route(s): | PERCUTANEOUS; SUBCUTANEOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 54575-098 | 
| Labeler Name: | Allergy Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | BLA101376 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 19671207 | 
| Package NDC: | 54575-098-30 | 
| Package Description: | 30 mL in 1 VIAL, MULTI-DOSE (54575-098-30) | 
| NDC Code | 54575-098-30 | 
| Proprietary Name | QUACK GRASS POLLEN | 
| Package Description | 30 mL in 1 VIAL, MULTI-DOSE (54575-098-30) | 
| Product NDC | 54575-098 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | elymus repens pollen | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | PERCUTANEOUS; SUBCUTANEOUS | 
| Start Marketing Date | 19671207 | 
| Marketing Category Name | BLA | 
| Labeler Name | Allergy Laboratories, Inc. | 
| Substance Name | ELYMUS REPENS POLLEN | 
| Strength Number | 1 | 
| Strength Unit | g/20mL | 
| Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |